Inventor · disambiguated record
Carlos Puig Duran
Also filed as: PUIG DURAN CARLOS
15 granted patents·8 pending applications·77 citations·filing 2003–2018
91Inventor score
Top patents by PatentIndex Score
23 records- 0189US7964615B2Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the β2 adrenergic receptorALMIRALL SA·Filed 2006·Granted Jun 21, 2011·15 cites·24 claims
- 0287US9233108B2Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activitiesALMIRALL SA·Filed 2012·Granted Jan 12, 2016·9 cites·3 claims
- 0382US9562039B2Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both β2 adrenergic receptor agonist and M3 muscarinic receptor antagonist activitiesALMIRALL SA·Filed 2014·Granted Feb 7, 2017·10 cites·11 claims
- 0481US9315463B2Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activitiesPRAT QUINONES MARIA·Filed 2011·Granted Apr 19, 2016·15 cites·25 claims
- 0579US9757383B2Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activitiesALMIRALL SA·Filed 2015·Granted Sep 12, 2017·2 cites·7 claims
- 0679US9549934B2Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activitiesALMIRALL SA·Filed 2015·Granted Jan 24, 2017·2 cites·3 claims
- 0777US8420669B2Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the BETA2 adrenergic receptorPUIG DURAN CARLOS·Filed 2011·Granted Apr 16, 2013·4 cites·6 claims
- 0877US8283342B2Napadisylate salt of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one as agonist of the β2 adrenergic receptorPUIG DURAN CARLOS·Filed 2008·Granted Oct 9, 2012·6 cites·4 claims
- 0975US10005771B2Bicyclic derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activitiesALMIRALL SA·Filed 2015·Granted Jun 26, 2018·2 cites·26 claims
- 1074US9643961B2Cyclohexylamine derivatives having β2 adrenergic antagonist and M3 muscarinic antagonist activitiesALMIRALL SA·Filed 2016·Granted May 9, 2017·2 cites·3 claims
- 1173US9579316B2Salts of 2-amino-1-hydroxyethyl-8-hydroxyquinolin-2(1H)-one derivatives having both muscarinic receptor antagonist and β2 adrenergic receptor agonist activitiesALMIRALL SA·Filed 2014·Granted Feb 28, 2017·3 cites·9 claims
- 1267US9518050B2Cyclohexyl and quinuclidinyl carbamate derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activityALMIRALL SA·Filed 2013·Granted Dec 13, 2016·2 cites·46 claims
- 1365US7622480B2Azaindolylpiperidine derivatives as antihistaminic and antiallergic agentsALMIRALL LAB·Filed 2003·Granted Nov 24, 2009·5 cites·21 claims
- 1460US10300072B2Cyclohexylamine derivatives having β2 adrenergic agonist and M3 muscarinic antagonist activitiesALMIRALL SA·Filed 2017·Granted May 28, 2019·0 cites·24 claims
- 1550US2010168161A1Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptorALMIRALL LAB·Filed 2007·Application pending·0 cites
- 1646US2020255478A1Novel compounds activating the nrf2 pathwayALMIRALL SA·Filed 2018·Application pending·0 cites
- 1743US2011028442A1Derivatives of 4-(2-amino-1-hydroxyethyl) phenol as agonists of the beta2 adrenergic receptorPUIG DURAN CARLOS·Filed 2009·Application pending·0 cites
- 1843US2009082378A1Derivatives of 4-(2-amino-1-hydroxiethyl)phenol as agonists of the b2 adrenergic receptorPUIG DURAN CARLOS·Filed 2007·Application pending·0 cites
- 1941US2014303127A1New cyclohexylamine derivatives having beta 2 adrenergic agonist and m3 muscarinic antagonist activitiesALMIRALL SA·Filed 2012·Application pending·0 cites
- 2040US2015210643A1Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptorBACH TAÑA Jordi·Filed 2012·Application pending·0 cites
- 2136US2015065471A1Salts of 5-[(1r)-2-(amino)-1-hydroxyethyl]-8-hydroxyquinolin-2(1h)-oneALMIRALL SA·Filed 2013·Application pending·0 cites
- 2232US10456390B2Combinations comprising MABA compounds and corticosteroidsALMIRALL SA·Filed 2014·Granted Oct 29, 2019·0 cites·18 claims
- 2329US2016015704A1Combinations comprising maba compounds and corticosteroidsALMIRALL SA·Filed 2014·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Carlos Puig Duran files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →